Becton, Dickinson and Company, a manufacturer of medical supplies and devices, completed underwritten public notes offerings consisting of offerings of $600 million and €1 billion by Becton Dickinson and an offering of €800 million by Becton Dickinson Euro Finance, an indirect finance subsidiary of Becton Dickinson.
The proceeds will fund a portion of Becton Dickinson’s acquisition of Edwards Lifesciences Corporation’s Critical Care business.
S&C represented the underwriters in each offering. The US Dollar offering was led by Citigroup Global Markets Inc., Barclays Capital Inc., BNP Paribas Securities Corp., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC. The Euro offerings were led by Citigroup Global Markets Limited, Barclays Bank PLC, BNP Paribas, J.P. Morgan Securities plc and Wells Fargo Securities International Limited.
The S&C team included Bob Downes, Joyce Lee, Gao Song, Natasha Rygnestad-Stahl and Jean Polanun. Jeff Hochberg advised on tax matters. Tracey Russell advised on FINRA matters. Kirsten Rodger and Anna McLaughlin advised on U.K. and EEA matters.